Disease-modifying anti-rheumatic drugs (DMARDs) are the standard treatments for RA. They are used either alone or in combination with newer biologic DMARDs.
DMARDs do not have any common properties other than their ability to slow down the progression of rheumatoid arthritis. Many were used for other diseases and were found accidentally to help RA. DMARDs include:
A study published online in the March 2007 issue of Arthritis Care & Research finds that image concerns are linked to depression in... Read more »
Is there an association between rheumatoid arthritis and systemic lupus erythematosus (lupus)? Can someone have both diseases or must he or... Read more »
Through 29 years of living with rheumatoid arthritis, I have experienced both painful flares and periods of remission. I have tried many... Read more »
In the early 20th century, Swedish physician Henrik Sjögren (SHOW-gren) first described a group of women whose chronic arthritis was... Read more »
Today rheumatologists (arthritis specialists) have powerful tools to help patients with rheumatoid arthritis (RA), but it was not always... Read more »
A review of previous studies has found a link between the use of tumor necrosis factor (TNF) inhibitors such as Remicade (infliximab), Enbrel... Read more »
The U.S. Food and Drug Administration (FDA) has approved a new drug for people who suffer from arthritis related to immune-system disorders. The... Read more »
Source: ADAM Encyclopedia
The course of rheumatoid arthritis differs from person to person. For some patients, they disease becomes less aggressive over time and symptoms may... Read more »
Source: Medifocus Guidebook on: Rheumatoid Arthritis
Goals of Treatment for Rheumatoid ArthritisThe primary goals of treatment for rheumatoid arthritis (RA) include: Alleviating joint-related symptoms... Read more »
Rheumatoid and psoriatic arthritis are among the most disabling forms of arthritis. Rheumatoid arthritis (RA), which affects 1 percent of the U.S.... Read more »